Search

Displaying results 591 - 600 of 7399 in total
  1. Indication

    Inadequate response or intolerance to DMARDs

    go.drugbank.com/conditions/DBCOND0125171
    Drugs: Anakinra · Certolizumab pegol · Filgotinib · Methotrexate · Risankizumab · Sarilumab +3 more
    Synonyms: Inadequate response or intolerance to DMARDs
  2. Indication

    Inadequate response to other therapeutic measures

    go.drugbank.com/conditions/DBCOND0106210
    Drugs: Alemtuzumab · Canrenoic acid · Eltrombopag · Enoximone · Hydrochlorothiazide · Lanreotide +8 more
    Synonyms: Insufficient response to other therapies, Insufficient response to other therapy
  3. Indication

    Mild Dementia due to Parkinson's disease

    go.drugbank.com/conditions/DBCOND0025346
    Drugs: Rivastigmine
    Synonyms: Mild Dementia due to Parkinson's disease
  4. Indication

    Mutations amenable to exon 53 skipping

    go.drugbank.com/conditions/DBCOND0124903
    Drugs: Golodirsen · Viltolarsen
    Synonyms: Mutations amenable to exon 53 skipping
  5. Indication

    Positive response to octreotide or lanreotide

    go.drugbank.com/conditions/DBCOND0130368
    Drugs: Octreotide
    Synonyms: Positive response to octreotide or lanreotide
  6. Indication

    Testicular failure due to bilateral torsion

    go.drugbank.com/conditions/DBCOND0112668
    Drugs: Testosterone cypionate
    Synonyms: Testicular failure due to bilateral torsion
  7. Indication

    Unable to tolerate ursodeoxycholic acid (UDCA)

    go.drugbank.com/conditions/DBCOND0127971
    Drugs: Elafibranor · Obeticholic acid · Seladelpar
    Synonyms: Unable to tolerate ursodeoxycholic acid (UDCA)
  8. Drug

    Magnesium citrate

    go.drugbank.com/drugs/DB11110
    ApprovedInvestigational

    [T215] Magnesium citrate is considered by the FDA as an approved inactive ingredient for approved drug products under the specifications of oral administration of a maximum concentration of 237 mg.

    Products: MAGGZİUM 400 MG ORAL ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 20 ADET, MAGGZİUM 400 MG ORAL ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 50 ADET
  9. Drug

    Hydrochlorothiazide

    go.drugbank.com/drugs/DB00999
    ApprovedInvestigationalVet approved

    [A185138] It is indicated to treat edema and hypertension.[A185138,L8447,L8450] Hydrochlorothiazide use is common but declining in favour of angiotensin converting enzyme inhibitors.

    Mixtures: Nu-lisinopril/hctz, Nu-lisinopril/hctzProducts: TOP- K, Nu-hydro
  10. Drug

    Triclosan

    go.drugbank.com/drugs/DB08604
    Approved

    An aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group.

    Mixtures: T-Chem E2 Rated, TALCO MEDICADO T 24Products: Antibacterial Skin Rain Forest Extract From Entiere, Lysol No Touch